Resumen
Gender identity is the intrinsic perception of a person to be a man, woman or some gender alternative. Transgender people feel that they are in the wrong body, since they feel the opposite sex to the assigned. When this incongruence between gender identity and the physical phenotype generates great anguish, anxiety and persistent discomfort, it is called gender dysphoria. It is estimated that 0.4% -1.3% of the world population experience different degrees of Gender Dysphoria. (3), and not all people with gender dysphoria have the same needs, so the evaluation of the personal goal to achieve well-being is very important. All medical interventions involve risks, so the understanding of the latter, adherence and management by trained professionals minimizes them. In the Journal of the Chilean Society of Obstetrics and Child and Adolescent Gynecology, we have recently published two review articles on the introduction to Hormonotherapy in transgender people, objectives of therapy, transition in adolescence, and the male to female transition, so this writing will focus only on the Risks of Hormonal Therapy in the transition.
Título traducido de la contribución | Hormonal therapy in transgender people according to the World Professional Association for Transgender Health (WPATH) and clinical guidelines of the Endocrine Society |
---|---|
Idioma original | Español |
Páginas (desde-hasta) | 426-441 |
Número de páginas | 16 |
Publicación | Revista Chilena de Obstetricia y Ginecologia |
Volumen | 83 |
N.º | 4 |
DOI | |
Estado | Publicada - 1 sep. 2018 |
Palabras clave
- Contraindications hormonotherapy in transgender
- Female to male transition
- Female transgender
- Gender dysphoria
- Risks Hormonotherapy in transgender
- Transgender male
Áreas temáticas de ASJC Scopus
- Ginecología y obstetricia